T cells encountering myeloid cells programmed for amino acid-dependent immunosuppression use Rictor/mTORC2 protein for proliferative checkpoint decisions
Open accessAbstract
Modulation of T cell proliferation and function by immunoregulatory myeloid cells are an essential means of preventing self-reactivity and restoring tissue homeostasis. Consumption of amino acids such as arginine and tryptophan by immunoregulatory macrophages is one pathway that suppresses local T cell proliferation. Using a reduced complexity in vitro macrophage-T cell co-culture system, we show that macrophage arginase-1 is the only factor required by M2 macrophages to block T cells in G 1 , and this effect is mediated by l-arginine elimination rather than metabolite generation. Tracking how T cells adjust their metabolism when deprived of arginine revealed the significance of macrophage-mediated arginine deprivation to T cells. We found mTORC1 activity was unaffected in the initial G 1 block. After 2 days of arginine deprivation, mTORC1 activity declined paralleling a selective down-regulation of SREBP target gene expression, whereas mRNAs involved in glycolysis, gluconeogenesis, and T cell activation were unaffected. Cell cycle arrest was reversible at any point by exogenous arginine, suggesting starved T cells remain poised awaiting nutrients. Arginine deprivation-induced cell cycle arrest was mediated in part by Rictor/mTORC2, providing evidence that this nutrient recognition pathway is a central component of how T cells measure environmental arginine.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Lactate produced from upregulated glycolysis in PDAC cells combines with GM-CSF, released in a KRAS-dependent fashion, to stimulate macrophage polarization.
“Lactate produced from upregulated glycolysis in PDAC cells combines with GM-CSF, released in a KRAS-dependent fashion, to stimulate macrophage polarization260.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [260]
TAM programming is mediated by oncogenic KRAS reprogramming of PDAC cells.
“The programming of TAMs is mediated by oncogenic-KRAS reprogramming of PDAC cells.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [260]
TAM polarization occurs through a PI3K-AKT pathway that activates ACLY signaling and expression of the arginine catabolic enzyme Arg1.
“The polarization of TAMs occurs through a PI3K-AKT pathway, activating ACLY signaling and the expression of the arginine catabolic enzyme Arginase 1 (Arg1).”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [260]
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · see citing works
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · see citing works
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · see citing works
Self-citationTLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690 · see citing works
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · see citing works
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · see citing works
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · see citing works
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775 · see citing works
The role of interleukin-2 during homeostasis and activation of the immune system
Boyman, O., & Sprent, J. (2012) · Nature reviews. Immunology · doi:10.1038/nri3156 · Cited by 1,656 · see citing works
mTOR differentially regulates effector and regulatory T cell lineage commitment
Delgoffe, G. M., Kole, T., Zheng, Y., Zarek, P. E., Matthews, K., Xiao, B., Worley, P., Kozma, S., & Powell, J. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,293 · see citing works
Delgoffe, G. M., Pollizzi, K. N., Waickman, A. T., Heikamp, E., Meyers, D. J., Horton, M. R., Xiao, B., Worley, P. F., & Powell, J. D. (2011) · Nature Immunology · doi:10.1038/ni.2005 · Cited by 1,111 · see citing works
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
Munn, D. H., & Mellor, A. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.001 · Cited by 1,037 · see citing works
L-arginine availability regulates T-lymphocyte cell-cycle progression.
Rodriguez, P. C., Quiceno, D. G., & Ochoa, A. C. (2007) · Blood · doi:10.1182/blood-2006-06-031856 · Cited by 926 · see citing works
Amino acid signalling upstream of mTOR
Jewell, J. L., Russell, R. C., & Guan, K.-L. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3522 · Cited by 894 · see citing works
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Chantranupong, L., Scaria, S. M., Saxton, R. A., Gygi, M. P., Shen, K., Wyant, G. A., Wang, T., Harper, J. W., Gygi, S. P., & Sabatini, D. M. (2016) · Cell · doi:10.1016/j.cell.2016.02.035 · Cited by 843 · see citing works
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
Pesce, J. T., Ramalingam, T. R., Mentink-Kane, M. M., Wilson, M. S., El Kasmi, K. C., Smith, A. M., Thompson, R. W., Cheever, A. W., Murray, P. J., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000371 · Cited by 816 · see citing works
Self-citationWang, S., Tsun, Z., Wolfson, R. L., Shen, K., Wyant, G., Plovanich, M. E., Yuan, E. D., Jones, T. D., Chantranupong, L., Comb, W. C., et al. (2015) · Science · doi:10.1126/science.1257132 · Cited by 772 · see citing works
LXR signaling couples sterol metabolism to proliferation in the acquired immune response
Bensinger, S. J., Bradley, M. N., Joseph, S. B., Zelcer, N., Janssen, E. M., Hausner, M. A., Shih, R., Parks, J. S., Edwards, P. A., Jamieson, B. D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.052 · Cited by 711 · see citing works
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Rebsamen, M., Pochini, L., Stasyk, T., de Araújo, M. E. G., Galluccio, M., Kandasamy, R. K., Snijder, B., Fauster, A., Rudashevskaya, E. L., Bruckner, M., et al. (2015) · Nature · doi:10.1038/nature14107 · Cited by 673 · see citing works
El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., König, T., Schleicher, U., Koo, M.-S., et al. (2008) · Nature Immunology · doi:10.1038/ni.1671 · Cited by 646 · see citing works
Self-citationSaturated fatty acids activate TLR-mediated proinflammatory signaling pathways
Huang, S., Rutkowsky, J. M., Snodgrass, R. G., Ono‐Moore, K. D., Schneider, D. A., Newman, J. W. I., Adams, S. H., & Hwang, D. H. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d029546 · Cited by 591 · see citing works
Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
Levin, A. M., Bates, D. L., Ring, A. M., Krieg, C., Lin, J. T., Su, L., Moraga, I., Raeber, M. E., Bowman, G. R., Novick, P. A., et al. (2012) · Nature · doi:10.1038/nature10975 · Cited by 552 · see citing works
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
Bronte, V., Serafini, P., Santo, C. D., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Löwel, M., Sutter, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.270 · Cited by 513 · see citing works
l -Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes
Rodrı́guez, P. C., Zea, A. H., DeSalvo, J., Culotta, K. S., Zabaleta, J., Quiceno, D. G., Ochoa, J. B., & Ochoa, A. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1232 · Cited by 494 · see citing works
Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2
Demetriades, C., Doumpas, N., & Teleman, A. A. (2014) · Cell · doi:10.1016/j.cell.2014.01.024 · Cited by 412 · see citing works
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
Keller, T. L., Zocco, D., Sundrud, M. S., Hendrick, M., Edenius, M., Yum, J., Kim, Y. J., Lee, H., Cortese, J. F., Wirth, D. F., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.790 · Cited by 395 · see citing works
Yang, K., Shrestha, S., Zeng, H., Karmaus, P. W. F., Neale, G. A. M., Vogel, P., Guertin, D. A., Lamb, R. F., & Chi, H. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.015 · Cited by 389 · see citing works
Self-citationGundra, U. M., Girgis, N. M., Ruckerl, D., Jenkins, S., Ward, L. N., Kurtz, Z. D., Wiens, K. E., Tang, M. S., Basu-Roy, U., Mansukhani, A., et al. (2014) · Blood · doi:10.1182/blood-2013-08-520619 · Cited by 371 · see citing works
Infectious tolerance via the consumption of essential amino acids and mTOR signaling
Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J., Mellor, A. L., Ron, D., & Waldmann, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903919106 · Cited by 336 · see citing works
Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production
Rutschman, R. L., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A., & Murray, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2173 · Cited by 324 · see citing works
Self-citationMechanism of arginine sensing by CASTOR1 upstream of mTORC1
Saxton, R., Chantranupong, L., Knockenhauer, K., Schwartz, T., & Sabatini, D. (2016) · Nature · doi:10.1038/nature19079 · Cited by 301 · see citing works
Yang, K., Neale, G. A. M., Green, D. R., He, W., & Chi, H. (2011) · Nature Immunology · doi:10.1038/ni.2068 · Cited by 294 · see citing works
Self-citationNorian, L. A., Rodrı́guez, P. C., O’Mara, L. A., Zabaleta, J., Ochoa, A. C., Cella, M., & Allen, P. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2826 · Cited by 270 · see citing works
Amino acid auxotrophy as a system of immunological control nodes
Murray, P. J. (2016) · Nature Immunology · doi:10.1038/ni.3323 · Cited by 248 · see citing works
Self-citationHuber, S., Hoffmann, R. F. G., Muskens, F., & Voehringer, D. (2010) · Blood · doi:10.1182/blood-2010-02-271981 · Cited by 207 · see citing works
Marigo, I., Zilio, S., Desantis, G., Mlecnik, B., Agnellini, A. H. R., Ugel, S., Sasso, M. S., Qualls, J. E., Kratochvill, F., Zanovello, P., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.08.004 · Cited by 204 · see citing works
Self-citationRegulation of T cells by mTOR: the known knowns and the known unknowns
Pollizzi, K. N., & Powell, J. D. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.11.005 · Cited by 196 · see citing works
Qualls, J. E., Subramanian, C., Rafi, W., Smith, A. M., Balouzian, L., DeFreitas, A. A., Shirey, K. A., Reutterer, B., Kernbauer, E., Stockinger, S., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.07.012 · Cited by 184 · see citing works
Self-citationMacrophage activation governs schistosomiasis‐induced inflammation and fibrosis
Barron, L., & Wynn, T. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141869 · Cited by 183 · see citing works
Self-citationEl-Gayar, S., Thüring, H., Pfeilschifter, J. M., Röllinghoff, M., & Bogdan, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4561 · Cited by 180 · see citing works
Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
Carroll, B., Maetzel, D., Maddocks, O., Otten, G., Ratcliff, M., Smith, G. R., Dunlop, E., Passos, J., Davies, O. R., Jaenisch, R., et al. (2016) · eLife · doi:10.7554/elife.11058 · Cited by 177 · see citing works
Coordination of Lipid Metabolism in Membrane Biogenesis
Nohturfft, A., & Zhang, S. C. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175344 · Cited by 175 · see citing works
Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity
Offman, M. N., Król, M., Patel, N. R., Krishnan, S., Liu, J., Saha, V., & Bates, P. A. (2010) · Blood · doi:10.1182/blood-2010-07-298422 · Cited by 164 · see citing works
Distinct Dimer Interaction and Regulation in Nitric-oxide Synthase Types I, II, and III
Panda, K., Rosenfeld, R. J., Ghosh, S., Meade, A. L., Getzoff, E. D., & Stuehr, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203749200 · Cited by 126 · see citing works
Arginase I Suppresses IL-12/IL-23p40–Driven Intestinal Inflammation during Acute Schistosomiasis
Herbert, D. R., Orekov, T., Roloson, A., Ilies, M., Perkins, C. L., O’Brien, W. E., Cederbaum, S. D., Christianson, D. W., Zimmermann, N., Rothenberg, M. E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902009 · Cited by 125 · see citing works
Vannella, K., Barron, L., Borthwick, L., Kindrachuk, K. N., Narasimhan, P., Hart, K. M., Thompson, R. W., White, S., Cheever, A., Ramalingam, T., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004372 · Cited by 108 · see citing works
Self-citationMicroenvironmental arginine depletion by macrophages in vivo
Currie, G. A., Gyure, L. A., & Cifuentes, L. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.112 · Cited by 95 · see citing works
Nascimento, M., Huang, S. C., Smith, A. M., Everts, B., Lam, W. Y., Bassity, E., Gautier, E. L., Randolph, G. J., & Pearce, E. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004282 · Cited by 90 · see citing works
Self-citationRoss, S. H., Rollings, C., Anderson, K. E., Hawkins, P. T., Stephens, L. R., & Cantrell, D. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.022 · Cited by 89 · see citing works
Role of Arginase 1 from Myeloid Cells in Th2-Dominated Lung Inflammation
Barron, L., Smith, A. M., Kasmi, K. C. E., Qualls, J. E., Huang, X., Cheever, A. W., Borthwick, L. A., Wilson, M. S., Murray, P. J., & Wynn, T. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061961 · Cited by 84 · see citing works
Self-citationWerner, A., Amann, E., Schnitzius, V., Habermeier, A., Luckner‐Minden, C., Leuchtner, N., Rupp, J., Closs, E. I., & Munder, M. (2015) · European Journal of Immunology · doi:10.1002/eji.201546047 · Cited by 82 · see citing works
de Velde, L.-A. V., Guo, X.-Z. J., Barbaric, L., Smith, A. M., Oguin, T. H., Thomas, P. G., & Murray, P. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.079 · Cited by 82 · see citing works
Self-citationModulation of human lymphocyte proliferation by amino acids
Chuang, J.-L., YU, C. L., & WANG, S. R. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05310.x · Cited by 55 · see citing works
CAT2 arginine transporter deficiency significantly reduces iNOS‐mediated NO production in astrocytes
Manner, C. K., Nicholson, B., & MacLeod, C. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01695.x · Cited by 53 · see citing works
Loveday, D., Heacock, A. M., & Fisher, S. K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02021.x · Cited by 39 · see citing works
de Velde, L.-A. V., & Murray, P. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.c116.763623 · Cited by 33 · see citing works
Self-citationNjau, F., Geffers, R., Thalmann, J., Haller, H. G., & Wagner, A. D. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.07.006 · Cited by 32 · see citing works
Waysbort, N., Russ, D., Chain, B., & Friedman, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301575 · Cited by 31 · see citing works
CD4+ TCR Repertoire Heterogeneity in Schistosoma mansoni-Induced Granulomas
Hogan, L. H., Wang, M., Suresh, M., Co, D. O., Weinstock, J. V., & Sándor, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6386 · Cited by 31 · see citing works
Turner, J. M. (1993) · International Immunology · doi:10.1093/intimm/5.10.1199 · Cited by 30 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321 · see citing works
Extracellular vesicles in immunomodulation and tumor progression
Marar, C., Starich, B., & Wirtz, D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00899-0 · Cited by 597 · see citing works
Steggerda, S. M., Bennett, M. K., Chen, J., Emberley, E. D., Huang, T. C., Janes, J. R., Li, W., MacKinnon, A. L., Makkouk, A., Marguier, G. M., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0308-4 · Cited by 488 · see citing works
Self-citationMetabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 378 · see citing works
Yang, L., Chu, Z., Liu, M., Zou, Q., Li, J., Liu, Q., Wang, Y., Wang, T., Xiang, J., & Wang, B. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01453-1 · Cited by 363 · see citing works
Metabolic orchestration of the wound healing response
Eming, S. A., Murray, P. J., & Pearce, E. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.017 · Cited by 319 · see citing works
Self-citationCzystowska, M., Sosnowska, A., Nowis, D., Ramji, K., Szajnik, M. E., Chlebowska, J., Wolińska, E., Gaj, P., Grażul, M., Pilch, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10979-3 · Cited by 315 · see citing works
Tharp, K. M., Kersten, K., Maller, O., Timblin, G. A., Stashko, C., Canale, F. P., Menjivar, R. E., Hayward, M.-K., Berestjuk, I., ten Hoeve, J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00775-4 · Cited by 304 · see citing works
Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
Rodrı́guez, P. C., Ochoa, A. C., & Al-Khami, A. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00093 · Cited by 287 · see citing works
Recent Advances in Type-2-Cell-Mediated Immunity: Insights from Helminth Infection
Harris, N. L., & Loke, P. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.015 · Cited by 211 · see citing works
mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
Huang, H., Long, L., Zhou, P., Chapman, N. M., & Chi, H. (2020) · Immunological Reviews · doi:10.1111/imr.12845 · Cited by 193 · see citing works
Altered cancer metabolism in mechanisms of immunotherapy resistance
Ramapriyan, R., Caetano, M. S., Barsoumian, H. B., Mafra, A. C. P., Zambalde, É. P., Menon, H., Tsouko, E., Welsh, J. W., & Cortez, M. A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.004 · Cited by 171 · see citing works
Miyamoto, T., Murakami, R., Hamanishi, J., Tanigaki, K., Hosoe, Y., Mise, N., Takamatsu, S., Mise, Y., Ukita, M., Taki, M., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0407 · Cited by 154 · see citing works
Wnt Signaling in Cancer Metabolism and Immunity
El‐Sahli, S., Xie, Y., Wang, L., & Liu, S. (2019) · Cancers · doi:10.3390/cancers11070904 · Cited by 123 · see citing works
Munshi, S., Loh, M. K., Ferrara, N., DeJoseph, M. R., Ritger, A., Padival, M., Record, M. J., Urban, J. H., & Rosenkranz, J. A. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.11.023 · Cited by 117 · see citing works
Miyamoto, T., Murakami, R., Hamanishi, J., Tanigaki, K., Hosoe, Y., Mise, N., Takamatsu, S., Mise, Y., Ukita, M., Taki, M., et al. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14989/doctor.k23801 · Cited by 112 · see citing works
IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer
Zeitler, L., & Murray, P. J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104827 · Cited by 95 · see citing works
Self-citationWerner, A., Koschke, M., Leuchtner, N., Luckner‐Minden, C., Habermeier, A., Rupp, J., Heinrich, C., Conradi, R., Closs, E. I., & Munder, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00864 · Cited by 98 · see citing works
Turning cold tumors into hot tumors to ignite immunotherapy
Liu, Y., Wang, Y., Wang, S., Li, J., He, W. A., Fan, X.-J., & Wan, X. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02477-6 · Cited by 107 · see citing works
Nutrients: Signal 4 in T cell immunity
Raynor, J. L., & Chi, H. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20221839 · Cited by 94 · see citing works
Metabolic features of macrophages in inflammatory diseases and cancer
Na, Y. R., Je, S., & Seok, S. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.044 · Cited by 94 · see citing works
Wu, R., Chen, X., Kang, S., Wang, T., Gnanaprakasam, J. R., Yao, Y., Liu, L., Zheng, S. G., Fan, G., Burns, M. R., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc4275 · Cited by 87 · see citing works
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
Lv, Y., Li, Z., Liu, S., Zhou, Z., Jinling, S., Ba, Y., Weng, S., Zuo, A., Xu, H. W., Luo, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02407-6 · Cited by 83 · see citing works
Chen, F., El-Naccache, D. W., Ponessa, J. J., Lemenze, A. D., Espinosa, V., Wu, W., Lothstein, K. E., Jin, L., Antao, O. Q., Weinstein, J. S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110215 · Cited by 61 · see citing works
Self-citationImmunometabolism of tumor-associated macrophages: A therapeutic perspective
Karimova, A. F., Khalitova, A. R., Suezov, R. V., Markov, N., Mukhamedshina, Y. O., Rizvanov, A. A., Huber, M., Simon, H., & Brichkina, A. I. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115332 · Cited by 64 · see citing works
Zhang, J., Yi, C., Han, J., Ming, T., Zhou, J., Lu, C., Li, Y., & Su, X. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1941 · Cited by 57 · see citing works
Spatially mapping the tumour immune microenvironments of non-small cell lung cancer
Desharnais, L., Sorin, M., Rezanejad, M., Liu, B., Karimi, E., Atallah, A., Swaby, A. M., Yu, M. W., Doré, S., Hartner, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56546-x · Cited by 58 · see citing works
Boronic acid-based arginase inhibitors in cancer immunotherapy
Borek, B., Gajda, T., Gołȩbiowski, A., & Błaszczyk, R. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115658 · Cited by 54 · see citing works
Biswas, A., Shouval, D. S., Griffith, A. E., Goettel, J. A., Field, M., Kang, Y. H., Konnikova, L., Janssen, E., Redhu, N. S., Thrasher, A. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03670-6 · Cited by 51 · see citing works
Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1–Dependent Myeloid Cells
de Velde, L.-A. V., Allen, E. K., Crawford, J. C., Wilson, T. L., Guy, C. S., Russier, M., Zeitler, L., Bahrami, A., Finkelstein, D., Pelletier, S. W., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0691 · Cited by 50 · see citing works
Self-citationSanctis, F. D., Lamolinara, A., Boschi, F., Musiu, C., Caligola, S., Trovato, R., Fiore, A., Frusteri, C., Anselmi, C., Poffe, O., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003549 · Cited by 46 · see citing works
Yap, G. S., & Gause, W. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02135 · Cited by 41 · see citing works
The Adaptive Complexity of Cancer
Derbal, Y. (2018) · BioMed Research International · doi:10.1155/2018/5837235 · Cited by 40 · see citing works
Integrating T cell metabolism in cancer immunotherapy
Dugnani, E., Pasquale, V., Bordignon, C., Canu, A., Piemonti, L., & Monti, P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.039 · Cited by 38 · see citing works
Kim, Y., Sundrud, M. S., Zhou, C., Edenius, M., Zocco, D., Powers, K., Zhang, M., Mazitschek, R., Rao, A., Yeo, C., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913788117 · Cited by 40 · see citing works
Fu, L., Fu, S., Wang, C., Xie, M., & Wang, Y. (2019) · Allergology International · doi:10.1016/j.alit.2019.05.013 · Cited by 37 · see citing works
Han, J., Dong, L., Wu, M., & Ma, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160340 · Cited by 35 · see citing works
Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0317 · Cited by 33 · see citing works
Xu, B., Ye, L., Tang, Y., Zheng, J., Tian, X., Yang, Y., & Yang, Z. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.08.011 · Cited by 30 · see citing works
Paduch, K., Debus, A., Rai, B., Schleicher, U., & Bogdan, C. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801249 · Cited by 29 · see citing works
Tumor Immune Microenvironment in Gynecologic Cancers
Margul, D. J., Yu, C., & AlHilli, M. M. (2023) · Cancers · doi:10.3390/cancers15153849 · Cited by 24 · see citing works
Lange, S., McKell, M. C., Schmidt, S., Hossfeld, A. P., Chaturvedi, V., Kinder, J. M., McAlees, J. W., Lewkowich, I. P., Way, S. S., Turner, J., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01561 · Cited by 25 · see citing works
Self-citationWorms: Pernicious parasites or allies against allergies?
McSorley, H. J., Chayé, M. A. M., & Smits, H. H. (2018) · Parasite Immunology · doi:10.1111/pim.12574 · Cited by 25 · see citing works
Angka, L., de Souza, C. T., Baxter, K. E., Khan, S., Market, M., Martel, A. B., Tai, L., Kennedy, M. A., Bell, J. C., & Auer, R. C. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.024 · Cited by 22 · see citing works
Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment
Vitorakis, N., Gargalionis, A. N., Papavassiliou, K. A., Adamopoulos, C., & Papavassiliou, A. G. (2024) · Cancers · doi:10.3390/cancers16162876 · Cited by 22 · see citing works
Metabolic manipulation of the tumour immune microenvironment
Wan, M., Ding, Y., Li, Z., Wang, X., & Xu, M. (2021) · Immunology · doi:10.1111/imm.13444 · Cited by 20 · see citing works
Gene-selective transcription promotes the inhibition of tissue reparative macrophages by TNF
Dichtl, S., Sanin, D. E., Koss, C. K., Willenborg, S., Petzold, A., Tanzer, M. C., Dahl, A., Kabat, A. M., Lindenthal, L., Zeitler, L., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202101315 · Cited by 18 · see citing works
Self-citationLercher, A., Popa, A., Viczenczová, C., Kosack, L., Klavins, K., Agerer, B., Opitz, C. A., Lanz, T. V., Platten, M., & Bergthaler, A. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008973 · Cited by 18 · see citing works
Metabolic orchestration of T lineage differentiation and function
Yong, C. S. M., Moussa, D. A., Cretenet, G., Kinet, S., Dardalhon, V., & Taylor, N. N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12849 · Cited by 16 · see citing works
Detection and functional evaluation of arginase-1 isolated from human PMNs and murine MDSC
Canè, S., & Bronte, V. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.022 · Cited by 16 · see citing works
Expanding TOR Complex 2 Signaling: Emerging Regulators and New Connections
An, P., Xu, W., Luo, J., & Luo, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.713806 · Cited by 15 · see citing works
Doshi, A. S., Cantin, S., Hernandez, M., Srinivasan, S. S., Tentarelli, S., Griffin, M., Wang, Y., Pop-Damkov, P., Prickett, L. B., Kankkonen, C., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0431 · Cited by 13 · see citing works
Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment
Bonilla, M. E., Radyk, M. D., Perricone, M. D., Elhossiny, A. M., Harold, A. C., Medina-Cabrera, P. I., Kadiyala, P., Shi, J., Frankel, T. L., Carpenter, E. S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.180114 · Cited by 12 · see citing works
Scaglione, M., Knight, M., Trihemasava, K., Rome, K., Archambault, A., Oh, J., Tanaka, E., Hall, E., Le, T. N. V., Lines, C. L., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.04.004 · Cited by 10 · see citing works
Myeloid mechano-metabolic programming restricts anti-tumor immunityPreprint
Tharp, K. M., Kersten, K., Maller, O., Timblin, G. A., Stashko, C., Canale, F. P., Hayward, M.-K., Berestjuk, I., ten Hoeve-Scott, J., Samad, B., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.14.499764 · Cited by 8 · see citing works
Heyndrickxia coagulans as a next-generation probiotic: current evidence and future perspectives
Ke, S., Chen, Z., Qi, Y., Zhang, J., Chen, Q., Chen, J., & Bo, H. (2025) · Food & Function · doi:10.1039/d5fo03559g · Cited by 7 · see citing works
Systematic analysis of TREM2 and its carcinogenesis in pancreatic cancer
Zheng, W., Yu, W., Hua, R., He, J., Wu, N., Tian, S., Huang, W., & Qin, L. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-201 · Cited by 6 · see citing works
Meli, A. P., Russell, G. A., Swaminathan, S., Weichselbaum, L., MacMahon, C. A., Pernet, E., Karo‐Atar, D., Rogers, D., Rochette, A., Fontès, G., et al. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.08.004 · Cited by 5 · see citing works
Pearl, J. E., Das, M., & Cooper, A. M. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.145 · Cited by 4 · see citing works
The regulatory role and mechanism of energy metabolism and immune response in head and neck cancer
Li, H., Qiu, P., Oyang, L., Yang, W., Li, S., Han, Y., Peng, M., Tan, S., Xia, L., Lin, J., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101607 · Cited by 3 · see citing works
Differential cell survival outcomes in response to diverse amino acid stress
Russier, M., Fiore, A., Bici, A., Groß, A., Tanzer, M., Yeroslaviz, A., Mann, M., & Murray, P. J. (2025) · Life Science Alliance · doi:10.26508/lsa.202503324 · Cited by 3 · see citing works
Self-citationFoglia, B., Nurcis, J., Signorini, M., & Cannito, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1823145 · Cited by 3 · see citing works
Biosynthetic plasticity enables CD8+ T cell functional resilience under nutrient stressPreprint
Scaglione, M., Knight, M., Trihemasava, K., Rome, K., Archambault, A., Oh, J., Tanaka, E., Hall, E., Le, T. N. V., Lines, C. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.22.632829 · Cited by 3 · see citing works
Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics
Huang, S., Ou, Y., Zhuang, W., Huang, J., Wang, B., Li, Z., & Huang, H. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189586 · Cited by 2 · see citing works
Chen, F., El-Naccache, D. W., Ponessa, J. J., Lemenze, A. D., Espinosa, V., Wu, W., Lothstein, K. E., Jin, L., Rivera, A., Siracusa, M. C., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3725764 · Cited by 1 · see citing works
Chen, F., El-Naccache, D. W., Ponessa, J. J., Lemenze, A. D., Espinosa, V., Wu, W., Lothstein, K. E., Jin, L., Antao, O. Q., Weinstein, J. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.02.322388 · Cited by 1 · see citing works
Self-citationAli, Y., Galbraith, T., Abdelfattah, N., Žiemys, A., Wong, T. L., Hashimoto, C., Faisal, M., Xu, Q., Cook, H., Pandita, T. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.26.661471 · Cited by 1 · see citing works
Moreira, C., Hétru, J., Paiola, M., Duflot, A., Chan, P., Vaudry, D., Pinto, P., Monsinjon, T., & Knigge, T. (2021) · Comparative Biochemistry and Physiology - Part D:Genomics and Proteomics · doi:10.1016/j.cbd.2021.100911 · Cited by 1 · see citing works
Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2023) · doi:10.1158/2326-6066.c.6550171
Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2023) · doi:10.1158/2326-6066.c.6550171.v1
Therapeutic Potential of Extracellular Vesicles from Different Cell Sources
Wang, X., & Li, Z. (2023) · doi:10.1002/9783527842155.ch3
Kynurenine Metabolism Mediates Tumor Progression in Renal Cell CarcinomaPreprint
Miller, K. M., Rounseville, S. P., Castro-Portuguez, R., Railey, R., Dang, H. T. L., Dundore, K., Espejo, L. S., Freitas, S., & Sutphin, G. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.705186
张晓娟, Liu, Y., Hou, Y., & Niu, H. (2026) · MedComm · doi:10.1002/mco2.70884
Research progress on the interconnected network of mitophagy and energy metabolism in tumors
赵康杓, Du, Y., Fang, J., Cao, M., & Wang, X. (2026) · ONCOLOGIE · doi:10.1515/oncologie-2026-0244
BindingDB Entry 50012858: Boronic acid-based arginase inhibitors in cancer immunotherapy.
BindingDB (2022) · UC San Diego · doi:10.7270/q2ws8xzc
- Authors
- Van de Velde, L.-A., Subramanian, C., Smith, A. M., Barron, L., Qualls, J. E., Neale, G., Alfonso-Pecchio, A., Jackowski, S., Rock, C. O., Wynn, T. A., & Murray, P. J.
- Affiliations
- St. Jude Children's Research Hospital (US)
- National Institutes of Health (US)
- Corresponding author
- Murray, Peter J.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 292
- Issue
- 1
- Pages
- 15-30
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC5217675
- OpenAlex
- W2558185744
- Cited by
- 75
- References
- 61
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 5 · 2023: 10 · 2022: 6 · 2021: 8 · 2020: 9 · 2019: 6 · 2018: 6 · 2017: 9
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AI062921, CA138064, CA21765)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- T cell proliferation, immunosuppression, M2 macrophages, arginine deprivation, arginase-1, mTORC1, amino acid sensing, cell cycle arrest, T cell metabolism
- MeSH terms
- Mechanistic Target of Rapamycin Complex 2, Rapamycin-Insensitive Companion of mTOR Protein, Animals, Arginine, Carrier Proteins, Cells, Cultured, Immune Tolerance, Immunosuppression Therapy, Lymphocyte Activation, Mice, Inbred BALB C, Mice, Inbred C57BL, T-Lymphocytes, Mice, Knockout, Coculture Techniques, Myeloid Cells, Multiprotein Complexes, Cell Proliferation, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases, Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review